Using millers anaesthesiology book discuss in detail without missing important scores, classifications, tables, relevant things to remember as a MD anaesthesia student, about the following topics - anaesthetic management of a patient with SDH with midline shift on conservative management from neurosurgery side now posted for both bone fracture right leg

Checking Date & Time
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Now let me read the key Miller's blocks in parallel — the ICP management, tight brain checklist, and ICP monitoring for non-neurologic surgery sections:
Reading File
Reading File
Reading File
Reading File
Excellent content found. Now let me read more critical sections — osmotherapy, blood pressure management, monitoring, and GCS:
Reading File
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
I now have sufficient content from Miller's to write a comprehensive answer. Let me update todos and compose the full response.Here is the complete, detailed discussion drawn from Miller's Anesthesia, 10th Edition:

Anaesthetic Management: SDH with Midline Shift (Conservative Neurosurgical Management) Posted for Bone Fracture Right Leg


THE CLINICAL SCENARIO — Framing the Challenge

This patient presents with a unique double jeopardy:
  • An active intracranial pathology (subdural haematoma [SDH] with midline shift, on conservative management — meaning the neurosurgical team has judged it does not yet warrant surgical evacuation)
  • An urgent orthopaedic procedure (long-bone fracture of the right leg, likely requiring either regional or general anaesthesia)
The anaesthetist's challenge is to safely conduct an anaesthetic for a non-neurological procedure in a patient with an unstable intracranial milieu. Every anaesthetic decision must be filtered through the lens: "Will this intervention worsen ICP, reduce CPP, or precipitate brain herniation?"

PART 1 — UNDERSTANDING THE INTRACRANIAL PATHOPHYSIOLOGY

1.1 The Monro-Kellie Doctrine

The skull is a rigid box containing three contents:
ComponentNormal VolumeCompressible?
Brain parenchyma~1400 mLMinimally
CSF~150 mLYes (initially)
Blood (CBV)~150 mLYes (initially)
When SDH adds volume, initial compensation occurs by CSF and venous blood displacement. Once this compensatory reserve is exhausted, even small increases in volume produce exponential rises in ICP (the volume-pressure relationship). Midline shift on CT signals this compensatory reserve is significantly depleted.
"When the cranium is closed, the objectives are to maintain adequate CPP (CPP = MAP – ICP) and prevent the herniation of brain tissue between intracranial compartments or through the foramen magnum."Miller's Anesthesia, 10e (Chapter 53)

1.2 CT Findings Signalling Elevated ICP / Reduced Compliance

Miller's specifically lists these as critical CT warning signs:
  • Midline shift ✅ (present in this patient)
  • Obliteration of basal cisterns
  • Loss of sulci / sulcal effacement
  • Ventricular effacement
  • Hypodense areas = vasogenic oedema
The basal cisterns appear as a dark (hypodense) halo around the upper brainstem on CT — comprising the interpeduncular cistern, quadrigeminal cistern, and ambient cisterns. Their obliteration signals transtentorial herniation risk.

1.3 Clinical Signs of Raised ICP

SignNotes
Headache (nocturnal — wakes from sleep)Classical raised ICP headache
Nausea and vomitingEspecially projectile
Blurred vision / papilloedemaSign of chronic/subacute rise
Somnolence / altered consciousnessGCS decline = red flag
Cushing's TriadHypertension + Bradycardia + Irregular respirations (sign of impending herniation)

1.4 Herniation Pathways (Miller's Fig. 53.1)

TypeDescription
Sub-falcineCingulate gyrus displaced under falx
Uncal (transtentorial)Uncus herniates through tentorial incisura — CN III palsy, contralateral hemiparesis
Cerebellar (upward or tonsillar)Through foramen magnum — sudden cardiovascular/respiratory collapse
TranscalvarialThrough craniotomy defect (post-operative)

PART 2 — PREOPERATIVE ASSESSMENT

2.1 Glasgow Coma Scale (GCS) — Mandatory Assessment

ComponentResponseScore
Eye OpeningSpontaneous4
To voice3
To pain2
None1
Verbal ResponseOriented5
Confused4
Inappropriate words3
Sounds only2
None1
Motor ResponseObeys commands6
Localises5
Withdraws4
Abnormal flexion3
Extension2
None1
Key thresholds:
  • GCS ≤ 8: Airway no longer reliably protected — intubation required
  • GCS < 15 after TBI: CT scan is mandatory
  • GCS < 15 with any intracranial lesion on CT → consider ICP monitor for surgery within 48 hours
"If there has been a loss of consciousness at any time or if the GCS score is less than 15, a CT scan should be obtained. If the CT reveals compressed basal cisterns, midline shift, or effaced ventricles, an ICP monitor should be considered for surgery with general anesthesia performed within 48 hours after TBI."Miller's Anesthesia, 10e (Chapter 53, ICP Monitoring for Non-Neurologic Surgery)

2.2 The "Talk and Die" / Delayed Deterioration Phenomenon

Miller's explicitly warns:
"Excessive comfort should not be taken from a good GCS score. Patients with good scores can talk and deteriorate or talk and die after a TBI associated with loss of consciousness. Delayed deterioration has been observed as much as 4 days after the initial injury."
Patients at highest risk of delayed deterioration:
  • Frontal and frontotemporal contusions
  • Medial temporal lesions (near uncus/incisura — herniation can occur at relatively low ICP ≥20 mmHg)

2.3 World Federation of Neurological Surgeons (WFNS) Scale

GradeGCS ScoreMotor Deficit
Grade 115Absent
Grade 213–14Absent
Grade 313–14Present
Grade 47–12Absent or present
Grade 53–6Absent or present
(Primarily for SAH, but used clinically for all intracranial pathologies to grade neurological status)

2.4 Injury Severity Score (ISS) — For the Combined Trauma Patient

AIS RegionScore 1–6ISS = Sum of squares of top 3
Head/neckSDH + midline shiftLikely AIS 4–5
Lower extremityLong-bone fractureAIS 2–3
Other regionsAs applicable
ISS >15 = major trauma. Clinically significant fat embolism syndrome (FES) is more likely underdiagnosed in patients with multiple injuries or high ISS.

2.5 Three Key Variables for Non-Neurological Surgery Decision (Miller's)

  1. Level of consciousness — GCS, CT findings, ICP monitor consideration
  2. Time since injury — Delayed deterioration up to 4–4.5 days; if within this window with CT lesion + GCS <15 → ICP monitoring strongly advised
  3. Nature and duration of the intended procedure — A 6-hour spine instrumentation in prone position carries far greater ICP risk than a 20-minute wound debridement

PART 3 — RECURRENT ISSUES IN NEUROANESTHESIA (Box 53.1, Miller's)

Every decision for this patient must address each of these:
IssueRelevance to This Patient
Control of ICP / brain relaxationPrimary concern — SDH with midline shift
Management of PaCO₂Hyperventilation has dual benefit and risk
Management of arterial BPMAP drives CPP; hypotension is catastrophic
Use of steroidsNOT recommended for TBI (increased mortality)
Use of osmotherapyMannitol / HTS may be needed
Use of diureticsFurosemide as adjunct
Use of anticonvulsantsSeizures raise CMR and ICP
Patient positioningHead-up 30°, avoid neck rotation
Neurophysiologic monitoringICP monitor consideration
IV fluid managementIsotonic only; avoid hypotonic and albumin
Glucose managementNormoglycaemia mandatory
Emergence from anaesthesiaSmooth — avoid coughing, bucking, hypertension

PART 4 — ICP TARGETS AND CPP MANAGEMENT

4.1 ICP Threshold

  • Normal ICP: 5–15 mmHg
  • Treatment threshold: ICP > 22 mmHg (Brain Trauma Foundation guidelines, updated)
  • Lethal ICP: Sustained > 40 mmHg

4.2 CPP Targets

"CPP should be kept between 60 and 70 mmHg, as higher or lower values worsen outcome after head trauma."
TargetValue
ICP treatment threshold> 22 mmHg
CPP minimum60 mmHg
CPP optimal range60–70 mmHg
CPP aggressive (avoid)> 90 mmHg (increases risk of respiratory failure)
MAP goalMaintain within 10% of awake values
Hypotension (absolute avoidance)SBP < 90 mmHg
"A single episode of systolic hypotension below 90 mm Hg may double mortality in patients with severe head injury."
Age-adjusted SBP targets (BTF guidelines):
Age GroupMinimum SBP
15–49 years or ≥ 70 years≥ 110 mmHg
50–69 years≥ 100 mmHg

4.3 Dysautoregulation — The Critical Concept

In normal brain, cerebral autoregulation maintains CBF constant across a MAP of 50–150 mmHg. After TBI/SDH:
  • Autoregulation may be lost → CBF becomes pressure-passive
  • Even "normal" MAP can cause ischaemia if resting CBF is already low (as commonly occurs in first 24 hours after injury)
  • Implication: Hypotension during anaesthetic induction/maintenance, even to normally acceptable levels, may produce cerebral ischaemia in these patients

PART 5 — PREOPERATIVE OPTIMISATION

Checklist Before Taking Patient to OR

Box 53.3 — High ICP ("Tight Brain") Checklist Applied Preoperatively:
1. Relevant pressures controlled?
  • Jugular venous pressure — avoid extreme head rotation, direct jugular compression; ensure head-up 30°
  • Airway pressure — airway obstruction? Bronchospasm? Excessive PEEP?
  • PaCO₂ and PaO₂ — normocapnia; normoxia
  • Arterial pressure — maintain MAP, avoid hypotension
2. Metabolic rate controlled?
  • Pain/arousal — adequate analgesia and sedation
  • Seizures — anticonvulsant therapy if indicated
  • Fever — normothermia (each 1°C rise increases CMR ~7%)
3. Potential vasodilators in use?
  • N₂O, volatile agents at high concentrations, nitroprusside, calcium channel blockers — all increase CBV/ICP
4. Unrecognised mass lesions?
  • Expanding SDH? Intracerebral haematoma? Air + N₂O expansion?

Pre-op Medications to Optimise

DrugPurposeNote
Mannitol 0.25–1 g/kg IVICP reduction if acutely elevatedOver 10–15 min; not bolus
Hypertonic saline 3%/7.5%/23.4%ICP reduction; may be superior in TBIVia central vein if >7.5%
Antiepileptic (levetiracetam/phenytoin)Seizure prophylaxis
DexamethasoneNOT for TBI/SDH (increased mortality in CRASH trial)Indicated for tumour oedema only
AnalgesicsAdequate pain control

PART 6 — ICP MONITORING DECISION

Indications for ICP Monitor Before This Surgery

Per Miller's (Chapter 53):
  • GCS < 15 after loss of consciousness + CT showing midline shiftstrong indication for ICP monitor
  • Surgery within 48 hours of TBI with CT lesion
  • Lengthy general anaesthesia planned
  • Frontal/temporal lesions at risk for delayed herniation
Methods of ICP Monitoring:
MethodAdvantagesDisadvantages
Ventricular catheter (EVD)Gold standard; allows CSF drainage; global ICPMore invasive; risk of bleeding and infection; may not be possible if ventricles compressed
Microtransducer (Strain gauge/fiberoptic)Less invasive; easier placementCannot drain CSF; measures only local compartment pressure
Noninvasive methodsNon-invasiveNot sufficiently reliable for continuous monitoring (research only)
"The ventricular catheter is still the gold standard of measurement as long as the ventricles are accessible, because they reflect global ICP and allow therapeutic drainage of CSF."
Practical decision for this scenario: Given midline shift (compressed ventricles may limit EVD placement), a microtransducer parenchymal ICP monitor is likely more feasible. Liaise with neurosurgery urgently.

PART 7 — ANAESTHETIC MANAGEMENT IN THE OPERATING ROOM

7.1 Goals of Anaesthesia

ABCDE of Neuroanesthesia in this context:
  1. Avoid hypotension — CPP = MAP – ICP; hypotension is lethal
  2. Avoid hypoxia — SpO₂ must be ≥ 95% continuously
  3. Control CO₂ — Normocapnia (PaCO₂ 35–38 mmHg); mild hyperventilation (30–35 mmHg) if ICP rises
  4. Avoid ICP surges — Smooth induction, intubation without coughing
  5. Euvolaemia with isotonic fluids — No hypotonic solutions; no albumin in TBI

7.2 Premedication

  • Anxiolytics with caution — avoid respiratory depression and CO₂ rise
  • Aspiration prophylaxis: consider full stomach protocol (trauma patients)
  • Continue antiepileptics

7.3 Monitoring

Standard monitors (mandatory):
  • ECG, SpO₂, NIBP (arterial line preferred — beat-to-beat BP)
  • Capnography (EtCO₂ — calibrate against PaCO₂; gradient usually 3–5 mmHg)
  • Temperature probe
  • Foley catheter (mandatory — osmotherapy causes diuresis)
Additional monitors (strongly recommended):
  • Invasive arterial line (radial artery) — essential for continuous MAP monitoring and ABG sampling
  • ICP monitor if placed (see Part 6)
  • Central venous access — for vasopressors and hypertonic saline >7.5%
  • BIS/Processed EEG — depth of anaesthesia
  • Neuromuscular monitoring (TOF) — especially to avoid coughing/bucking

7.4 Induction

Rapid Sequence Induction (RSI) considerations:
DrugEffect on ICPPreferred?
Propofol (1.5–2 mg/kg)↓ ICP, ↓ CMR, ↓ CBF✅ Yes — drug of choice
Thiopentone (3–5 mg/kg)↓ ICP strongly✅ Yes (if available)
KetamineOnce contraindicated; now acceptable in intubated/ventilated patients — no adverse ICP effectAcceptable in ventilated patients; avoid awake/spontaneous breathing
EtomidateMinimal haemodynamic effect; may ↑ seizure riskNOT recommended post severe TBI
Fentanyl/SufentanilNo ICP effect if MAP maintained✅ Use as co-induction
Lignocaine (1–1.5 mg/kg IV) 3 min before intubationAttenuates intubation pressor response✅ Recommended
SuccinylcholinePossibly increases ICPAvoid if possible; use rocuronium for RSI
Rocuronium (1.2 mg/kg)No ICP effect✅ Preferred for RSI
Key induction principles:
  • Pre-oxygenate thoroughly
  • Avoid hypotension at induction — the commonest cause of secondary brain injury in the OR
  • Attenuate laryngoscopy response — lignocaine IV, adequate depth before laryngoscopy
  • Head-up 30° tilt maintained during induction if possible
  • If RSI, use rocuronium + sugammadex available

7.5 Maintenance

Drug choices:
AgentEffect on ICP/CBFRecommendation
Propofol infusion↓ CMR, ↓ CBF, ↓ ICP✅ Excellent for TIVA — preferred in raised ICP; use BIS monitoring; watch for PRIS with >4 mg/kg/h
Volatile agents (sevoflurane <1 MAC)At low concentrations: minimal ICP effect✅ Acceptable at <1 MAC; higher concentrations cause cerebral vasodilation → ↑ ICP
Isoflurane, DesfluraneMore vasodilatory than sevoflurane at equipotent dosesUse with caution; desflurane has sympathomimetic pressor response during rapid increases
N₂O↑ CMR, ↑ CBF, expands intracranial pneumatocelesAVOID in SDH/TBI
Opioids (fentanyl, sufentanil, remifentanil)No ICP effect when MAP maintained✅ Use freely for analgesia; remifentanil ideal for context-sensitive titration
BenzodiazepinesLonger half-lifeLess suitable if neurological assessment needed post-op
KetamineAcceptable in ventilated patients; bronchodilator; reduces vasopressor need✅ In intubated/ventilated patients
BarbituratesMaximum CMR suppression; rescue ICP therapyFor refractory ICP; requires EEG monitoring

7.6 Ventilation Strategy

ParameterTarget
PaO₂80–120 mmHg (normoxia)
PaCO₂35–38 mmHg (normocapnia)
SpO₂≥ 95%
EtCO₂32–36 mmHg (accounting for gradient)
If ICP rises intraoperativelyShort-term hyperventilation: PaCO₂ 30–35 mmHg
Minimum PaCO₂ allowed23–25 mmHg (beyond this, ischaemia risk; no additional ICP benefit)
PEEP≤ 15 cmH₂O shown not to increase ICP if oxygenation requires it
Warning about prolonged hyperventilation: CBF normalises within 8–12 hours of sustained hyperventilation (CSF bicarbonate buffering). CBF reduction is not sustained — do not rely on it as a long-term ICP strategy.
"Hyperventilation should not be an automatic component of every neuroanesthetic. There should be an indication for its initiation. Hyperventilation has the potential to cause an adverse effect and should be withdrawn as the indication for it subsides."Miller's Anesthesia, 10e (Chapter 53)

7.7 Fluid Management

Rules in the neurosurgically compromised patient:
FluidRecommendation
0.9% NaCl (normal saline)✅ Acceptable — isotonic
Balanced crystalloids (Plasmalyte, Hartmann's)✅ Preferred by many
Hypotonic solutions (5% dextrose, 0.45% saline, Dextrose-saline)ABSOLUTELY AVOID — lower plasma osmolality → worsens cerebral oedema
AlbuminAVOID in TBI — SAFE trial sub-study showed increased mortality vs isotonic saline in TBI (GCS 3–8)
HES (hydroxyethyl starch)Avoid — renal injury and coagulopathy risk
Blood productsAs per massive haemorrhage protocol if significant bleeding
MannitolBolus 0.25–1 g/kg if ICP rises; max plasma osmolarity ~320 mOsm/L
Hypertonic salineBolus (not continuous infusion); via central line if >7.5%
Goal: Euvolaemia with isotonic fluids. Avoid both hypovolaemia (↓ CPP) and hypervolaemia (pulmonary oedema).
"Although retrospective data analysis suggests that positive fluid balance is not associated with refractory intracranial hypertension, an association between hypervolemia and pulmonary edema was observed."

7.8 Blood Pressure Management

  • Vasopressors of choice: Norepinephrine (noradrenaline) — maintains MAP without direct cerebral vasodilation
  • Phenylephrine: Acceptable; may reflex bradycardia
  • Avoid aggressive hypotension for haemostasis (permissive hypotension) — contraindicated in TBI
  • If haemorrhage from fracture: maintain SBP ≥ 100–110 mmHg; avoid SBP < 90 mmHg absolutely

7.9 Positioning

  • Head-up 30° — reduces ICP by facilitating venous drainage
  • Avoid extreme neck rotation or flexion — obstructs jugular venous drainage → ↑ ICP
  • Orthopaedic procedure (right leg): patient likely supine — generally compatible with head-up positioning
  • Leg positioning: fracture table, skin traction, or standard table depending on fracture type

PART 8 — SPECIFIC ISSUE: FAT EMBOLISM SYNDROME (FES) — The Hidden Danger

This is a particularly dangerous complication that the anaesthetist MUST anticipate.
"Intraoperative TEE has shown that most patients undergoing long-bone fracture manipulation experience microembolism of fat and marrow. After long-bone fractures, lung dysfunction occurs in almost all patients, ranging from minor laboratory abnormalities to fat embolism syndrome."Miller's Anesthesia, 10e (Chapter 62)

Gurd's Criteria for FES Diagnosis

Major criteria (≥1 required):
  • Petechial rash (axillae, chest, conjunctivae — but only in 20–50% of cases)
  • Respiratory insufficiency (PaO₂ < 60 mmHg on FiO₂ 0.4)
  • Cerebral involvement (not attributable to other cause)
Minor criteria:
  • Tachycardia > 110 bpm
  • Pyrexia > 38.5°C
  • Thrombocytopaenia
  • High ESR
  • Fat globules in urine/sputum
  • Retinal changes (fat emboli in retinal vessels)
  • Jaundice
  • Renal changes
Schonfeld Score for FES:
FeaturePoints
Petechiae5
Diffuse alveolar infiltrates4
Hypoxaemia (PaO₂ < 9.3 kPa)3
Fever > 38°C1
Heart rate > 120 bpm1
Respiratory rate > 30/min1
Score ≥ 5 = FES diagnosis
In this patient with SDH:
  • CNS component of FES will be potentiated by pre-existing intracranial pathology
  • Under GA, CNS changes will not be apparent — may manifest as failure to awaken post-surgery
  • Any worsening of alveolar–arterial O₂ gradient + CNS deterioration → consider FES
Management of FES:
  • High FiO₂, high PEEP mechanical ventilation
  • Supportive care
  • Consider converting intramedullary nailing → external fixation to reduce embolic load
  • For bilateral femur fractures: allow 1–2 days between successive nailing procedures

PART 9 — REGIONAL VERSUS GENERAL ANAESTHESIA DECISION

Box 62.8 & 62.9 — Miller's Comparison

Regional Anaesthesia — Advantages for this patient:
  • Allows continued neurological assessment (GCS monitoring maintained)
  • Avoidance of airway instrumentation and pressure response
  • Decreased blood loss
  • Better postoperative mental status
  • Lower incidence of DVT
  • Improved postoperative analgesia
Regional Anaesthesia — Disadvantages:
  • Peripheral nerve function difficult to assess post-op
  • Hemodynamic instability during placement → ↓ MAP → ↓ CPP (dangerous)
  • Requirement for sedation (may cloud neurological assessment)
  • May not be suitable if procedure prolonged
  • Patient may not cooperate
General Anaesthesia — Advantages:
  • Speed of onset
  • Duration — as long as needed
  • Allows positive-pressure ventilation (ICP management)
  • Multiple procedures possible
General Anaesthesia — Disadvantages:
  • Impairment of global neurologic examination (key concern)
  • Requirement for airway instrumentation (pressor response risk)
  • Haemodynamic management more complex

Recommendation for This Scenario

If right leg fracture is below-knee (tibial, fibular):
  • Spinal / epidural (neuraxial) anaesthesia with judicious sedation (minimising doses) is possible — allows continued neurological monitoring
  • Monitor carefully for sympatholysis-induced hypotension → have vasopressors ready
If right leg fracture is above-knee (femoral shaft) or requires intramedullary nailing:
  • General anaesthesia with TIVA (propofol + remifentanil) preferred
  • Strict BP management with arterial line
  • ICP monitor in situ if placed
Note: If the patient has GCS < 9 or declining GCS → General anaesthesia with RSI is mandatory.

PART 10 — INTRAOPERATIVE ICP RESCUE ALGORITHM

Box 53.4 — Methods for Rapid Reduction of ICP (After Checking Box 53.3)

If "tight brain" or acute ICP rise occurs intraoperatively:
  1. First: Work through the Checklist (Box 53.3)
    • Jugular venous pressure — head rotation? Compression? Head-up?
    • Airway pressure — obstruction, bronchospasm, straining, pneumothorax, excessive PEEP?
    • PaCO₂ and PaO₂
    • Arterial pressure
    • Pain/arousal, seizures, fever?
    • Vasodilator drugs in use (N₂O, volatile agents, vasodilators)?
    • Unrecognised haematoma, expanding SDH, air + N₂O?
  2. Rescue Measures (in escalating order):
    • Further reduce PaCO₂ to 23–25 mmHg (but not below!)
    • CSF drainage (EVD if in situ)
    • Diuresis (furosemide or mannitol)
    • CMR suppression: propofol bolus, barbiturates
    • MAP reduction (only if dysautoregulation confirmed)
    • Hyperosmolar therapy: mannitol 0.25–1 g/kg or hypertonic saline bolus
    • Surgical control (lobectomy / remove bone flap) — last resort

PART 11 — TREATMENT OF INTRACRANIAL HYPERTENSION — Stepwise Algorithm (Miller's Chapter 80)

StepIntervention
1Keep all physiologic variables normal: normotension, normocapnia (PaCO₂ 35–38), normoxia (PaO₂ 80–120), normothermia, normoglycaemia, normovolaemia
2Head-up 30°; avoid head rotation
3CPP 60–70 mmHg; avoid massive fluids or high-dose vasoconstrictors
4Normocapnia; if ICP > 20–25 mmHg → short-term hyperventilation (PaCO₂ 30–35 mmHg)
5Adequate sedation (propofol preferred for short half-life)
6CSF drainage via EVD if ventricles accessible
7Mannitol or hypertonic saline (bolus only; never prophylactic continuous infusion)
8Barbiturate therapy under EEG monitoring
9Fever control (normothermia)

PART 12 — OSMOTHERAPY SUMMARY

AgentDoseRouteNotes
Mannitol 20%0.25–1 g/kg (up to 1.5 g/kg for surgical relaxation)IV over 10–15 minMax serum osmolarity ~320 mOsm/L; causes diuresis — monitor fluid balance; may worsen oedema if BBB disrupted
Hypertonic saline 3%VariablePeripheral IVFor ICP reduction; bolus only
HTS 7.5%VariableCentral lineMore concentrated; central vein mandatory
HTS 23.4%30–60 mLCentral line onlyReserved for refractory ICP; rapid reduction
Furosemide0.5–1 mg/kgIVAdjunct to mannitol; maintains osmotic gradient; also ↓ CSF production
Mannitol + FurosemideCombinationFurosemide maintains gradient established by mannitol
"HTS may provide superiority in the combined effect on intracranial pressure and CPP burden compared to mannitol in TBI, although a clear clinical outcome benefit has not been shown." NaCl > 7.5% causes endothelial damage — must be given via central vein only.

PART 13 — SPECIAL DRUG CONSIDERATIONS

DrugDecisionRationale
SuccinylcholineAvoid if possiblePossibly raises ICP
KetamineAcceptable in ventilated patientsNo adverse ICP effect when intubated; favourable haemodynamic profile
N₂OAVOID↑ CMR, ↑ CBF, expands intracranial air pockets
EtomidateAvoid post severe TBIRisk of seizures; adrenal suppression
CorticosteroidsAVOID in TBI/SDHCRASH trial: increased mortality and morbidity
Propofol✅ Preferred sedative/inductionShort half-life; allows neurological examination; watch PRIS (>4 mg/kg/h prolonged use)
Volatile agents✅ Low concentration (<1 MAC sevoflurane)Avoid high concentrations → cerebral vasodilation
Narcotics (fentanyl, sufentanil, remifentanil)✅ No ICP effect when MAP maintainedUse freely for analgesia
Rocuronium✅ Preferred for RSINo ICP effect; reversed by sugammadex
DexmedetomidineAdjunct; minimal ICP effectUseful for sedation; preserves neurological assessment more than benzodiazepines

PART 14 — EMERGENCE AND POST-OPERATIVE MANAGEMENT

Goals for Emergence

The "smooth emergence" imperative:
  • Coughing, bucking, straining, Valsalva → acute ICP surge → herniation risk
  • Extubate only when patient is fully awake and cooperative with intact airway reflexes
  • OR: planned postoperative sedation and intubation in ICU if GCS declining or prolonged surgery
Risk stratification for extubation:
ConditionRecommendation
Pre-op GCS 15, stable SDHExtubate awake after good recovery
GCS 9–14, stableConsider extubation vs ICU sedated intubated
GCS ≤ 8Remain intubated; ICU post-op
SDH expanding on intraoperative courseUrgent neurosurgical review; remain intubated
Any new neuro deficitsRemain intubated; repeat CT urgently
Agents to facilitate smooth emergence:
  • Lignocaine 1 mg/kg IV 5 min before extubation
  • Remifentanil infusion to extubation (titrated down slowly)
  • Avoid sudden reversal of NMB (coughing risk)
  • Dexmedetomidine infusion (0.4–0.7 mcg/kg/hr) — reduces coughing on emergence

Post-operative ICU/HDU Monitoring

  • Hourly GCS assessment
  • Continuous ICP monitoring (if monitor in situ)
  • Maintain CPP 60–70 mmHg
  • PaCO₂ 35–38 mmHg on ventilator
  • Normothermia (antipyretics; cooling blanket)
  • Normoglycaemia (BSL 6–10 mmol/L; avoid hypoglycaemia)
  • DVT prophylaxis — mechanical (TED stockings, pneumatic compression) — chemical anticoagulation is contraindicated with SDH
  • Strict intake/output with electrolytes monitoring (osmotherapy causes electrolyte shifts)
  • Repeat CT head 24 hours post-op or any neurological deterioration

PART 15 — GLUCOSE AND TEMPERATURE MANAGEMENT

Glucose

TargetValueRationale
Blood glucose6–10 mmol/LHyperglycaemia → ↑ lactate, ↑ cytotoxic oedema; hypoglycaemia → cerebral energy failure
Avoid<4 mmol/L or >12 mmol/LBoth extremes worsen secondary brain injury

Temperature

  • Normothermia mandatory — fever ↑ CMR ~7% per °C → worsens ICP
  • Induced hypothermia (32–34°C): NOT recommended as of current evidence
    • EUROTHERM trial: no outcome benefit
    • Multiple RCTs: negative
    • Current BTF: no established role for hypothermia in TBI management

PART 16 — ONE-PAGE SUMMARY TABLE FOR EXAM

DomainKey Points
ICP threshold>22 mmHg treat; >40 mmHg critical
CPP target60–70 mmHg
Hypotension limitSBP <90 mmHg doubles mortality
PaCO₂35–38 mmHg; 30–35 if ICP↑; never <23 mmHg
PaO₂ target80–120 mmHg
Preferred inductionPropofol + fentanyl + rocuronium; attenuate laryngoscopy response
AVOID at inductionSuccinylcholine, ketamine (awake), etomidate
Preferred maintenanceTIVA propofol + remifentanil OR sevoflurane <1 MAC; NO N₂O
FluidsIsotonic only; avoid hypotonic, avoid albumin in TBI
OsmotherapyMannitol 0.25–1 g/kg bolus; HTS bolus (not infusion)
SteroidsABSOLUTELY CONTRAINDICATED in TBI/SDH
ICP monitorStrongly indicated: CT lesion + GCS <15 + surgery within 48 h
PositioningHead-up 30°; no neck rotation
Fat embolismAnticipate with long-bone manipulation; worsened by existing SDH
EmergenceSmooth only; remain intubated if GCS ≤ 8 or declining
Post-opHourly GCS; CPP monitoring; normothermia; normoglycaemia; no chemical DVT prophylaxis
HypothermiaNOT recommended (EUROTHERM trial negative)

REFERENCES (Miller's Anesthesia, 10e — Chapters Used)

  • Chapter 53: Neuroanesthesia — ICP management, herniation, osmotherapy, PaCO₂, blood pressure, Box 53.1, 53.3, 53.4
  • Chapter 53: ICP Monitoring for Non-Neurologic Surgery in the Brain-Injured Patient
  • Chapter 43: Fluid Management — fluid choices in neurosurgery, HTS vs mannitol
  • Chapter 62: Trauma Anaesthesia — fat embolism, long-bone fracture, GCS, RSI, regional vs general, Boxes 62.8, 62.9
  • Chapter 80: Neurocritical Care — TBI treatment algorithm, CPP/ICP targets, sedation, stepwise ICP management

Bottom Line for the MD Anaesthesia Student: This patient is a neuroanesthetic high-wire act. Every drug choice, every ventilator adjustment, and every fluid bolus has a direct impact on ICP and CPP. The mantra is: "Protect the CPP, control the ICP, anticipate the secondary injury, and emerge smoothly." Never forget that the SDH with midline shift means the compensatory reserve is gone — there is no room for error.This comprehensive discussion is drawn entirely from Miller's Anesthesia, 10th Edition (Chapters 53, 43, 62, and 80). Here are the key take-home points structured for your MD exam:

Quick Recall Framework

The 3 Cardinal Questions Before This Anaesthetic

  1. Is the ICP currently dangerous? (CT: midline shift = compensatory reserve depleted; GCS trend)
  2. How much time since the SDH? (Delayed deterioration risk up to 4–4.5 days)
  3. How long and demanding is the orthopaedic procedure? (Long surgery prone = higher ICP risk)

The Non-Negotiables

❌ NEVER✅ ALWAYS
Hypotension (SBP <90 doubles mortality)CPP 60–70 mmHg
N₂O (↑ICP, expands pneumatoceles)Normocapnia PaCO₂ 35–38 mmHg
Hypotonic fluids (worsen oedema)Isotonic fluids only
Steroids in TBI/SDH (↑mortality — CRASH trial)Head-up 30°, no neck rotation
Albumin in TBI (↑mortality — SAFE trial)ICP monitor if GCS <15 + CT lesion + surgery within 48h
Prolonged prophylactic hyperventilationNormothermia (hypothermia: no benefit — EUROTHERM)
Succinylcholine (↑ICP risk)Rocuronium for RSI
Etomidate post-TBI (seizures, adrenal suppression)Propofol TIVA as preferred maintenance

Scores to Know

  • GCS (3–15): <8 = intubate; <15 + CT lesion = ICP monitor for surgery within 48h
  • WFNS Scale (Grade 1–5): based on GCS + motor deficit
  • Fisher/Modified Fisher Scale: CT grading of SAH blood (relevant if traumatic SAH component)
  • ISS (Injury Severity Score): >15 = major trauma; FES more likely in high-ISS patients
  • Gurd's Criteria and Schonfeld Score (≥5 points) for Fat Embolism Syndrome

The Unique FES Risk

Long-bone fracture manipulation causes fat and marrow microembolism in virtually all patients. In your patient with an existing SDH, the CNS component of FES will be unmasked only as failure to wake up from GA — making the diagnosis harder and the consequences worse.

Using millers anaesthesiology book discuss in detail, relevant tables, numerical data, scores, scales and classifications which are important in cadaveric transplantation and extraction of multiple organs

Checking Date & Time
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Now let me read the key blocks in parallel — brain death pathophysiology, organ donor management, and the main transplant chapters:
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
I now have comprehensive content from Miller's. Let me update todos and compose the full detailed answer.Here is the complete, detailed discussion from Miller's Anesthesia, 10th Edition (Chapters 56, 57, 73, and 80):

Cadaveric Transplantation and Multiple Organ Procurement — Complete Anaesthetic Discussion

Miller's Anesthesia, 10th Edition


SECTION 1 — FRAMEWORK: TYPES OF CADAVERIC DONORS

1.1 Two Pathways to Cadaveric Donation

TypeFull NameDefinition
DBDDonation after Brain DeathBrain death declared by neurological criteria; cardiopulmonary function maintained by life support
DCDDonation after Circulatory (Cardiac) DeathCardiac arrest after planned withdrawal of life-sustaining therapy; or unexpected cardiac arrest
"Before the acceptance of brain death, all organs procured were from donors who suffered a cardiac demise (DCD, previously known as donation from a non-heart-beating donor). After the establishment of the Harvard criteria for brain death, DBD quickly became the principal source of organ donation."Miller's Anesthesia, 10e (Chapter 57)
  • In the USA (2021): DCD donors accounted for 30.2% of all deceased donors

SECTION 2 — BRAIN DEATH: DEFINITION, CRITERIA, DECLARATION

2.1 History and Legal Basis

  • Harvard criteria (1968): First codification of brain death
  • Brain death = Irreversible loss of ALL brain functions, including the brainstem
  • Two functions that must be irreversibly lost:
    1. Capacity to breathe
    2. Capacity for consciousness

2.2 Prerequisites Before Brain Death Testing

Per Miller's (Chapter 80 — Neurocritical Care):
  1. Irreversible cause of neurological dysfunction must be established
  2. Adequate systemic oxygenation and perfusion must be ensured
  3. Confounders must be excluded and corrected:
ConfounderAction Required
HypothermiaCore temperature must be corrected
Metabolic compromiseElectrolytes, acid-base normalised
Sedative / hypnotic drugsAdequate time for clearance; drug levels if available
Neuromuscular blocking drugsTOF must confirm no residual block

2.3 Clinical Examination for Brain Death

ComponentFinding in Brain Death
Level of consciousnessUnresponsive; GCS 3
Pupillary reflexFixed, dilated; no light response
Corneal reflexAbsent
Oculocephalic reflex (Doll's eyes)Absent
Oculovestibular reflex (Cold calorics)Absent
Gag reflexAbsent
Cough reflexAbsent
Motor response to painNo cerebral motor response (spinal reflexes may persist)

2.4 Apnea Test

  • Pre-oxygenate with 100% O₂ for 10 minutes
  • Baseline ABG: PaCO₂ must be 35–45 mmHg (normocapnia)
  • Disconnect from ventilator; deliver O₂ via tracheal catheter at 6 L/min
  • Observe for respiratory movements for 8–10 minutes
  • Repeat ABG at end: PaCO₂ must rise to ≥ 60 mmHg or ≥ 20 mmHg above baseline
  • No respiratory effort = positive apnea test (supports brain death)

2.5 Ancillary / Confirmatory Tests

Required when clinical examination cannot be completed:
TestWhat It Demonstrates
EEG (Electroencephalogram)Electrocerebral silence
Cerebral angiographyNo intracranial blood flow (gold standard)
Radionuclide brain scan (99mTc-HMPAO)Absent cerebral perfusion ("hollow skull" sign)
Transcranial DopplerAbsent or reverberant flow patterns
CT angiographyNo intracranial vascular opacification

SECTION 3 — MAASTRICHT CLASSIFICATION OF DCD DONORS

CategoryDescriptionControlled?
IDead on arrival at hospitalUncontrolled
IIUnsuccessful resuscitation (witnessed arrest)Uncontrolled
IIIImminent cardiac arrest — withdrawal of life support plannedControlled
IVCardiac arrest in a brain-dead donorControlled
Key point: Categories I and II = uncontrolled DCD (longer warm ischaemia time; higher risk). Categories III and IV = controlled DCD (most common in current practice).

DCD: Sequence After Life Support Withdrawal

  1. Decision to withdraw life support made independently of transplant team
  2. Comfort care medications (analgesia, anxiolytics) for patient
  3. Trachea extubated; life support stopped
  4. Death declared by physician not involved in transplantation
  5. Duration between cardiac cessation and death declaration: 2–5 minutes (to confirm irreversibility)
  6. Organ procurement begins immediately after declaration

University of Wisconsin (UW) DCD Prediction Score (Table 57.2)

Used to predict likelihood of cardiac arrest after extubation:
Score RangeInterpretation
8–12High probability of continued breathing after extubation — organs may not be usable
13–18Moderate probability
19–24Low probability of continued breathing — apnea and cardiac arrest imminent — ideal DCD donor
6 variables assessed; score calculated to guide transplant team preparedness and decision-making

SECTION 4 — PATHOPHYSIOLOGY OF BRAIN DEATH — TABLE 57.1

Miller's Table 57.1: Pathophysiologic Changes Associated with Brain Death

Sign/SymptomPathophysiologic MechanismIncidence (%)
HypertensionCatecholamine storm80–90%
HypotensionVasoplegia, hypovolaemia, myocardial dysfunction80–90%
Bradycardia and other arrhythmiasCatecholamine storm, myocardial damage25–30%
Pulmonary oedemaAcute blood volume diversion, capillary damage10–20%
Diabetes insipidusPosterior pituitary damage45–80% (up to 90% per text)
DICTissue factor release (thromboplastin from brain)30–55%
HypothermiaHypothalamic damage, reduced metabolic rate, vasodilationVaried
HyperglycaemiaDecreased insulin, increased insulin resistanceCommon

Two Phases of Cardiovascular Response to Brain Death

PhaseTimingPhysiology
Phase 1 — Catecholamine StormAcuteIntense vasoconstriction, ↑ SVR, hypertensive crisis, tachycardia, visceral ischaemia; myocardial dysfunction in 40% of potential heart donors
Phase 2 — VasoplegiaSustainedLoss of sympathetic tone, ↓ CO, blunted haemostatic responses, severe peripheral vasodilation, hypotension
"Echocardiographic evidence of myocardial dysfunction is observed in 40% of brain-dead donors under consideration for heart donation."

SECTION 5 — ENDOCRINE DERANGEMENTS IN BRAIN DEATH

Hormone/SystemEffect of Brain Death
ADH (posterior pituitary)Lost → Central Diabetes Insipidus (45–90%)
T3 / T4 (thyroid)Deficient (euthyroid sick syndrome)
ACTHDeficient → adrenal insufficiency
Growth hormoneDeficient
InsulinDeficient + resistance → hyperglycaemia
Body temperature controlLost → initial hyperpyrexia then hypothermia
CoagulationTissue thromboplastin release → DIC in up to 1/3 of isolated head injury patients

SECTION 6 — DONOR MANAGEMENT BEFORE PROCUREMENT

6.1 Haemodynamic Goals

ParameterTarget
Mean Arterial Pressure60–100 mmHg
Central Venous Pressure6–10 cmH₂O (euvolaemia)
Urine Output0.5–3 mL/kg/hr
Vasopressor choiceVasopressin (1st line for heart donors per ACC); Dopamine; Norepinephrine
FluidIsotonic crystalloid (Lactated Ringer's or 0.9% NaCl); avoid large-dose HES
"Adequate resuscitation, as evidenced by a MAP of 60–100 mmHg, may decrease cytokine levels and increase the number of organs available for transplantation."

6.2 Pulmonary Management (Lung Donor Protocol)

ParameterTarget
Tidal volume6–8 mL/kg predicted body weight
PEEP8–10 cmH₂O
Peak airway pressure< 35 cmH₂O
PaO₂/FiO₂ ratioInitial ratio < 300 mmHg should NOT exclude — reversible causes must be treated first
RecruitmentBronchoscopy for mucous plugs
Usable lung graftsOnly 15–25% of donated lungs used for transplant
"Fluid restriction increases the number of lung grafts available for transplantation."
Conflict in fluid management: Aggressive fluids for kidney/cardiovascular stability vs. fluid restriction for lung preservation. Goal = euvolaemia.

6.3 Hormonal Replacement Therapy (DBD Donors)

HormoneEffect / Indication
ADH / VasopressinTreats DI; reduces catecholamine requirements; improves kidney, liver, cardiac graft outcomes
Thyroid hormone (T3/T4)Improves organs transplanted per donor; improves cardiac recipient survival
MethylprednisoloneReduces inflammatory response; improves oxygenation; reduces lung water; increases lung yield; decreases inflammation in heart, liver, kidney
InsulinTarget glucose 120–180 mg/dL; poor glucose control adversely affects donor renal function

6.4 Electrolyte and Sodium Management

ElectrolyteTargetReason
Sodium130–170 mmol/LHypernatraemia >155 mmol/L → poor post-LT outcomes; donor Na <130 or >170 mmol/L → increased cardiac recipient mortality (European heart donor analysis)
Glucose120–180 mg/dLHyperglycaemia worsens donor renal function
TemperatureTraditionally normothermia; mild hypothermia 34–35°C reduces DGF in kidney donorsHypothermia not shown to improve non-kidney graft survival

SECTION 7 — EXTENDED CRITERIA DONORS AND DONOR RISK INDICES

7.1 Standard Criteria Donor (SCD) vs Extended Criteria Donor (ECD)

FeatureSCDECD
Donor ageUsually youngAdvanced age
Organ functionNormalReduced / borderline
Cold ischaemia timeShortProlonged
ComorbiditiesMinimalMay include HTN, DM
Prognosis of graftBetterHigher failure rate
"Donor risk is a relative term and should be best described as a continuum, not a dichotomy of SCD and ECD."

Box 57.1 — Kidney Donor Profile Index (KDPI) — 10 Variables

  1. Age
  2. Height
  3. Weight
  4. Ethnicity
  5. History of hypertension
  6. History of diabetes
  7. Cause of death
  8. Serum creatinine
  9. Hepatitis C virus status
  10. Donation after circulatory death (DCD)
KDPI scale: 1–100%. Higher KDPI = higher graft failure rate

Box 57.2 — Liver Donor Risk Index (DRI) — 8 Variables

  1. Age (four categories: >40, >50, >60, >70 years)
  2. Cause of death — CVA (lower risk) vs other
  3. Race — African-American (higher risk) vs other
  4. DCD — yes or no
  5. Partial or split graft — yes or no
  6. Height — increasing risk as height decreases below 170 cm
  7. Regional or national share — yes or no
  8. Cold ischaemia time

Clinical Implications of High-DRI/ECD Grafts for Anaesthesia

ComplicationIncreased Risk with ECD/High-DRI Grafts
Intraoperative hyperkalemiaDCD grafts, prolonged ischaemia, prolonged donor hospital stay
Post-reperfusion syndrome (PRS)More likely
Intraoperative bleedingMore likely
Postoperative reoperationMore likely
DGF (kidneys)Higher incidence with DCD
Ischaemic cholangiopathy (livers)Older donor + overweight + prolonged ischaemia

SECTION 8 — COLD ISCHAEMIA TIME: ORGAN-SPECIFIC LIMITS

OrganIdeal Cold Ischaemia TimeMaximum Tolerated
Heart< 4 hours4–6 hours
Lung< 6 hours6–8 hours
Liver< 12 hoursUp to 24 hours
Pancreas< 12–15 hours
Kidney< 24 hours (ideal)Up to 36 hours
Small bowel< 8–12 hours
"Cadaveric kidney transplantation is an urgent procedure since the ideal cold ischaemia goal for the kidney is under 24 hours."

Warm vs Cold Ischaemia

TypeDefinitionImpact
Warm ischaemiaTime organ is ischaemic at body temperature (before cold flush)Most damaging; causes direct cellular injury
Cold ischaemiaFrom cold perfusion/storage to reperfusion in recipientCellular metabolism slowed; more tolerated
Warm ischaemia in DCDSignificantly longer than DBDMajor reason for higher graft failure

SECTION 9 — ANAESTHETIC MANAGEMENT OF THE CADAVERIC DONOR DURING PROCUREMENT SURGERY

9.1 Key Points (Chapter 57)

  • Anaesthesia care required only for DBD donors (not DCD, except pre-mortem protocols)
  • Majority of procurement occurs at community hospitals, not tertiary centres
  • Surgical approach: midline laparotomy extended by sternotomy (wide exposure)
  • Aortic cannula placed for cold preservation solution flush
  • Ice applied to surgical field to protect organs

9.2 Order of Organ Removal (by ischaemic susceptibility)

OrderOrganRationale
1stHeartMost susceptible to ischaemia
2ndLungsSecond most susceptible
3rdLiver / PancreasModerate tolerance
4th (last)KidneysMost tolerant of ischaemia

9.3 Anaesthetic Drugs and Management

IssueManagement
Spinal reflex movementsCommon in brain-dead donors; require neuromuscular blockers
Hypertension from spinal reflexes / surgical stimulationVasodilators, opioids, volatile anaesthetics (preferred — provide ischaemic preconditioning and reduce ischaemia-reperfusion injury)
BradycardiaAtropine does NOT work in brain-dead donors; use isoproterenol (direct-acting chronotrope)
Haemodynamic instabilityIV fluids + vasoactive drugs; vasodilators (phentolamine / alprostadil for lung recovery) during cross-clamping to reduce SVR and distribute preservation solution evenly
HeparinAdministered before aortic cross-clamping
PA/CVP cathetersMust be withdrawn before cross-clamping if heart/lung recovery anticipated
Mechanical ventilationContinue until organ perfusion with cold solution begins; lungs ventilated beyond cross-clamping if lung recovery anticipated
End of anaesthesiaVentilation and anaesthesia care stopped once cold perfusion is established

9.4 What Volatile Anaesthetics Offer in Procurement

"Volatile anaesthetics are commonly preferred since they may provide additional benefits that include ischaemic preconditioning and the reduction of ischaemia–reperfusion injury."

SECTION 10 — MELD SCORE (MODEL FOR END-STAGE LIVER DISEASE)

This is the primary organ allocation tool for liver transplantation in the USA (UNOS system).

MELD Score Formula

$$\text{MELD} = 3.78[\ln(\text{serum bilirubin})] + 11.2[\ln(\text{INR})] + 9.57[\ln(\text{serum creatinine})] + 6.43$$
MELD Score3-Month Mortality Without Transplant
< 9< 2%
10–196%
20–2920%
30–3953%
≥ 4071%
MELD ScoreAnaesthetic Implications
< 15Standard LT candidate risk
15–25Moderate complexity; coagulopathy and haemodynamic instability expected
> 25High complexity; massive transfusion likely; ICU post-op expected
> 35Very high risk; maximal preparation required; near-universal post-op ICU with ventilator support
"Many liver transplant allocation systems are based on the MELD score." — Miller's Key Points, Chapter 56

MELD-Na (Updated MELD)

$$\text{MELD-Na} = \text{MELD} - \text{Na} - [0.025 \times \text{MELD} \times (140 - \text{Na})] + 140$$
  • Incorporates hyponatraemia (a marker of portal hypertension severity)
  • Higher MELD-Na → prioritised on transplant waiting list

SECTION 11 — KIDNEY TRANSPLANTATION: ANAESTHETIC MANAGEMENT

11.1 Preoperative Assessment

KDIGO Cardiac Evaluation Guidelines (Box 56.1):
  • ECG + history + physical for all candidates
  • Active cardiac disease → cardiology review before transplant listing
  • Asymptomatic high-risk candidates (diabetics, known CAD, poor functional capacity) → noninvasive CAD screening
  • Asymptomatic known CAD: do NOT revascularise solely to reduce perioperative cardiac events
  • Asymptomatic advanced triple-vessel CAD → may be excluded from transplant
"Many ESRD patients are deconditioned and unable to exercise. Scoring systems that use traditional CAD risk factors may underestimate the risk of occult CAD in ESRD patients."

11.2 Urgency

  • Cadaveric kidney transplant is an URGENT procedure — cold ischaemia goal < 24 hours
  • Living donor transplant = scheduled elective surgery

11.3 Intraoperative Goals

GoalRationale
Maintain renal perfusion pressureAdequate MAP for graft perfusion
Euvolaemia / mild hypervolaemiaRenal blood flow restoration
Avoid hypotensionGraft ischaemia
Urine output monitoringIndicator of graft function
Electrolyte managementESRD patients have baseline hyperkalaemia

11.4 Delayed Graft Function (DGF)

  • Defined as: need for dialysis within first week post-transplant
  • Higher incidence with: DCD grafts, ECD kidneys, prolonged cold ischaemia, large-dose HES in donor
  • Large doses of starch-based colloids in donors → associated with DGF

SECTION 12 — LIVER TRANSPLANTATION: ANAESTHETIC MANAGEMENT

12.1 Three Surgical Stages — The Anaesthetist's Framework

StageDescriptionAnaesthetic Challenge
Stage 1: Dissection (Pre-anhepatic)Mobilisation of liver; clamping hepatic artery firstBleeding from varices and adhesions; haemodynamic instability
Stage 2: Anhepatic PhasePortal vein clamped; native liver removed; graft implantedNo hepatic function → ↑ potassium, acidosis, hypothermia, ↓ glucose, ↑ coagulopathy; haemodynamic instability from caval clamping
Stage 3: Neohepatic PhaseVena cava unclamped; graft reperfusedPost-reperfusion syndrome; sudden ↑ K⁺; haemodynamic collapse; coagulopathy

12.2 Post-Reperfusion Syndrome (PRS)

  • Definition: ≥ 30% decrease in MAP from baseline, persisting for at least 1 minute, within the first 5 minutes after reperfusion
  • Mechanism: Efflux of cold, hyperkalaemic, acidic preservation solution from graft into systemic circulation
  • Complications: Hypotension, bradycardia, asystole, hyperkalemia, arrhythmias
  • Prevention/Treatment: Calcium chloride before reperfusion; bicarbonate; insulin/glucose for K⁺; vasopressors; reperfusion slowly

12.3 Rapid Sequence Induction (RSI) — Mandatory

  • All LT patients are at elevated aspiration risk:
    • Delayed gastric emptying (ESLD)
    • Ascites
    • Preoperative oral immunosuppressants/antibiotics
  • RSI is standard induction technique for all liver transplants

12.4 Vascular Access for Liver Transplant

AccessPurpose
Arterial line (radial or femoral)Beat-to-beat BP; frequent ABGs
Large-bore central venous accessPSI (percutaneous sheath introducer) or MAC (multi-lumen access catheter)
RIC (Rapid Infusion Catheter)High-volume resuscitation; flow ~500 mL/min
Double introducerRetransplantation or extensive prior abdominal surgery
"A rapid infusion system capable of high transfusion flow rates (approximately 500 mL/min) connected to a large-bore central venous catheter is standard."

12.5 Electrolyte Monitoring During Liver Transplant

ElectrolyteChangeManagement
Potassium↑ especially at reperfusion (from preservation solution)Insulin + glucose; furosemide; avoid aggressive K⁺ replacement pre-reperfusion; intraoperative dialysis if refractory
SodiumRisk of osmotic demyelination syndrome (ODS) if corrected too rapidlyIncrease in serum Na must be ≤ 8 mEq/L in 24 hours (previously 16 mEq/L threshold); current literature suggests ≤8 mEq/L
Ionised calcium↓ from citrate-rich blood products (citrate intoxication without hepatic function)IV Calcium chloride — mandatory
Ionised magnesium↓ from citrate; returns to normal after graft reperfusionMonitor
GlucoseTarget: ≤ 180 mg/dL; levels >180 associated with increased surgical site infections

12.6 Coagulation Management in Liver Transplant

Guided by VISCOELASTIC TESTING (Point of Care):
TestMeasuresUse
TEG (Thromboelastography)Clot formation, strength, fibrinolysisGuides blood product use
ROTEM (Rotational Thromboelastometry)Same, different terminologySame
PT/INRClotting factor deficiencyCan guide FFP use
Fibrinogen levelHypofibrinogenaemiaGuide cryoprecipitate / fibrinogen concentrate
Platelet countThrombocytopaeniaGuide platelet transfusion
Blood Products Available:
ProductIndication
FFPCoagulopathy; contains all pro- and anticoagulant factors including fibrinogen
PCC (4-factor)Factor II, VII, IX, X + Protein C & S; avoids TACO and TRALI risk of FFP; theoretic thrombosis risk
CryoprecipitateHypofibrinogenaemia; fibrinogen + Factor VIII + vWF
Fibrinogen concentrateTargeted fibrinogen replacement
PlateletsThrombocytopaenia with clinical bleeding
rFVIIa (recombinant)NOT RECOMMENDED — no clinical benefit; increased thrombotic events
"Administration of blood products and/or factor concentrates during liver transplantation should be reserved only for clinically significant bleeding; prophylactic administration is not recommended."

12.7 Post-Liver Transplant Survival Data

PeriodSurvival
1-year (index complication of cirrhosis, with transplant vs medical therapy)> 90% with transplant
1-year (overall)90–95%
5-year (US and Europe, adults)80–85%
5-year (paediatric)~95%

SECTION 13 — ACUTE LIVER FAILURE (ALF): SPECIAL CONSIDERATIONS

Definition

  • Encephalopathy + coagulopathy (INR ≥ 1.5) in a patient without prior liver disease with illness < 26 weeks duration

Incidence

  • ~1 case per million per year; ~2000–3000 cases/year in the USA

Prognosis by Aetiology

AetiologyPrognosis Without Transplant
Acetaminophen/paracetamolMost favourable
Ischaemic injuryFavourable
Hepatitis AFavourable
Non-acetaminophen DILIPoor
Acute Hepatitis BPoor
Wilson diseasePoor
Autoimmune hepatitisPoor

ALF Anaesthetic Management Points

  • Cerebral oedema with intracranial hypertension is the most lethal complication
  • Head-up 30°, neutral neck position to reduce ICP
  • Intubation + controlled ventilation for GCS decline or encephalopathy
  • Mannitol for osmotic diuresis (limited utility in renal compromise)
  • Plasma exchange / MARS (molecular adsorbent recirculating system) as bridge to transplant
  • Overall survival ALF: now >70% with modern care and transplantation

SECTION 14 — HEART TRANSPLANTATION

14.1 Indications (Paediatric — Chapter 73)

Age GroupMost Common Indication
< 1 yearCongenital heart malformations
AdolescentsCardiomyopathy
AdultsIschaemic cardiomyopathy > idiopathic cardiomyopathy

14.2 Pulmonary Vascular Resistance (PVR) Thresholds

PopulationPVR Exclusion Threshold
AdultsPVR > 6 Wood units/m² — contraindication to isolated heart transplant
Children/InfantsPVR up to 12 Wood units/m² may be accepted if responds to vasodilators (O₂, NO, Ca²⁺ channel blockers, prostacyclin)
"Most adult transplant programs will not offer heart transplant therapy to patients with PVR over 6 Wood units/m²."

14.3 Anaesthetic Management Principles for Heart Transplant

  • Careful titration of anaesthetic agents with minimal myocardial depressant characteristics
  • Avoid excessive opioids — can cause cardiovascular deterioration by reducing endogenous catecholamines
  • Airway and ventilation management critical in presence of elevated PVR
  • For Trendelenburg position for central line: may not be tolerated by decompensated patients — use level table + ultrasound

SECTION 15 — LUNG DONOR CONSIDERATIONS (DCD vs DBD)

FeatureDBD Lung DonorDCD Lung Donor
Usable for transplant15–25% of donated lungsVery few — susceptible to ischaemia
Proinflammatory stateYes — cytokine releaseLess (no brain death physiology)
Early graft failureRelated to donor inflammatory stateWarm ischaemia-related
Protective ventilation6–8 mL/kg PBW; PEEP 8–10 cmH₂OSame protocol
Initial PaO₂/FiO₂ < 300NOT grounds for exclusion aloneSame

SECTION 16 — PANCREAS TRANSPLANTATION

Types

  • SPK: Simultaneous Pancreas-Kidney transplant (most common — diabetic nephropathy)
  • PAK: Pancreas after Kidney
  • PTA: Pancreas Transplant Alone (brittle diabetes)

Preoperative Evaluation (Chapter 56)

  • Indication: definitive treatment for diabetes mellitus (including combined kidney transplantation in diabetic patients with renal failure)
  • High cardiovascular risk in diabetics — same KDIGO cardiac evaluation principles apply
  • Silent ischaemia more common in diabetics with ESRD

Anaesthetic Management Key Point

  • Close monitoring of blood glucose levels — perioperative requirement specific to pancreas transplant
  • Risk of hyperglycaemia (donor-related), then hypoglycaemia after reperfusion of functioning graft

SECTION 17 — SUMMARY: ORGAN ALLOCATION SCORES AND INDICES

Score/IndexOrganVariablesClinical Use
MELDLiverBilirubin, INR, CreatinineAllocation priority + surgical risk stratification
MELD-NaLiverMELD + SodiumReplaces MELD in US allocation
KDPI (Kidney Donor Profile Index)Kidney10 donor variablesGraft failure risk; 1–100% scale
Liver DRILiver8 donor variablesDonor risk of liver graft failure
UW DCD ScoreAll (DCD)6 variablesPredicts time to cardiac arrest after extubation; 8–24 scale
PVR (Wood units)Heart/LungHaemodynamicContraindication threshold for heart transplant
PaO₂/FiO₂ ratioLungABGLung graft quality assessment (initial <300 not exclusionary)
WFNS ScaleNeurologicalGCS + motor deficitNeurological classification of donor or acute injury severity
GCSNeurologicalEye, verbal, motorBrain death declaration prerequisite; donor neurological status

SECTION 18 — ONE-PAGE EXAM SUMMARY TABLE

DomainKey Numbers to Remember
DCD donors (USA, 2021)30.2% of all deceased donors
Brain death — Harvard criteria1968
Maastricht categoriesI–IV; controlled = III & IV
UW DCD Score8–24; 8–12 = still breathing; 19–24 = imminent arrest
Pathophysiology incidenceHTN: 80–90%; Hypotension: 80–90%; DI: 45–90%; DIC: 30–55%; Arrhythmias: 25–30%
Cardiac dysfunction in brain deathEchocardiographic abnormality in 40% of brain-dead heart donors
Lung utilisationOnly 15–25% of donated lungs used
Cold ischaemia time: Heart< 4 hours
Cold ischaemia time: Kidney< 24 hours
Donor MAP goal60–100 mmHg
Donor glucose target120–180 mg/dL
Donor Na thresholdHypernatraemia > 155 mmol/L → poor LT outcome
Lung ventilation: Vt6–8 mL/kg PBW; PEEP 8–10 cmH₂O; Ppeak < 35 cmH₂O
MELD ≥ 4071% 3-month mortality without transplant
LT 1-year survival90–95%
LT 5-year survival (adult)80–85%
Paediatric LT 5-year survival~95%
Na correction in LT (ODS prevention)8 mEq/L in 24 hours
Glucose limit for wound infection in LT> 180 mg/dL → increased SSI
RSI in liver transplantMandatory
Bradycardia in brain-dead donorAtropine INEFFECTIVE; use isoproterenol
Heparin in procurementBefore aortic cross-clamping
PVR cutoff (adult heart transplant)> 6 Wood units/m² = contraindication
PVR cutoff (paediatric, if vasodilator-responsive)Up to 12 Wood units/m² acceptable
KDPI variables10 donor variables
Liver DRI variables8 donor variables

REFERENCES — Miller's Anesthesia, 10e Chapters Used

  • Chapter 57: Organ Donation and Procurement — Table 57.1, Table 57.2, Box 57.1, Box 57.2; brain death; DCD; Maastricht classification; UW score; donor management
  • Chapter 56: Anaesthesia for Abdominal Organ Transplantation — MELD, kidney, liver, pancreas, intestinal transplantation; KDIGO guidelines; three phases of LT
  • Chapter 73: Paediatric Cardiac Anaesthesia — Heart transplantation PVR thresholds
  • Chapter 80: Neurocritical Care — Brain death declaration criteria and ethics

Examiner's Perspective: The highest-yield areas for MD anaesthesia exams in this topic are: (1) Table 57.1 incidence figures for brain death pathophysiology, (2) Maastricht classification and UW Score, (3) MELD score and its surgical risk implications, (4) three phases of liver transplantation and post-reperfusion syndrome, (5) organ-specific cold ischaemia times, and (6) procurement anaesthesia — neuromuscular blockers for spinal reflexes, isoproterenol for bradycardia, and the role of volatile anaesthetics.This is a complete, exam-ready discussion drawn entirely from Miller's Anesthesia, 10th Edition (Chapters 56, 57, 73, 80). Here's your quick orientation to the structure:

How to Use This for Exam Preparation

The 5 Pillars of This Topic:
  1. Brain Death — Harvard criteria (1968), prerequisites, clinical exam, apnea test (PaCO₂ must rise to ≥60 mmHg), ancillary tests, and the critical distinction between DBD and DCD
  2. Maastricht Classification (I–IV) + UW DCD Score (8–24) — These scores define the DCD donor pool and predict organ usability; Maastricht III & IV = controlled DCD (most used)
  3. Pathophysiology of Brain Death (Table 57.1) — The incidence figures are high-yield: hypertension AND hypotension both at 80–90%, DI at 45–90%, DIC at 30–55%. The two-phase cardiovascular response (catecholamine storm → vasoplegia) drives all donor management decisions
  4. MELD Score — The cornerstone of liver allocation and a direct predictor of surgical complexity; MELD >35 = high-risk anaesthesia territory with mandatory massive transfusion preparedness
  5. Procurement Anaesthesia — Only for DBD; organs removed heart-first, kidneys-last; atropine DOES NOT WORK for bradycardia (use isoproterenol); neuromuscular blockers for spinal reflexes; volatile agents preferred (ischaemic preconditioning benefit); heparin before cross-clamping

Using millers anaesthesiology book discuss in detail including scores, classifications, important must know informations about the topic anaesthetic management in a patient with road traffic accident, with SDH, SAH undergoing decompressive craniotomy with gcs of E4V3M6

Checking Date & Time
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Excellent — I now have the key file paths. Let me read the critical sections in parallel:
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
I now have comprehensive content from all relevant Miller's chapters. Let me compose the final comprehensive answer.# Anaesthetic Management: RTA with SDH + SAH, GCS E4V3M6, for Decompressive Craniotomy

Miller's Anesthesia, 10th Edition — Complete Discussion


UNPACKING THE CLINICAL SCENARIO

Patient profile:
  • Mechanism: Road Traffic Accident (RTA) → polytrauma, full stomach assumed, possible cervical spine injury
  • Intracranial injuries: Subdural Haematoma (SDH) + Subarachnoid Haemorrhage (SAH) — traumatic
  • Neurological status: GCS E4V3M6 = Total 13
  • Planned surgery: Decompressive craniotomy (evacuation of SDH + decompression)
Immediate risk calculation: GCS 13 places this patient at WFNS Grade II–III — a moderate-to-severe neurological insult with declining trajectory. The co-existence of traumatic SAH adds vasospasm risk, cerebral salt wasting risk, and cardiac stunning risk to what is already an acutely raised ICP scenario.

PART 1 — SCORING SYSTEMS AND CLASSIFICATIONS

1.1 Glasgow Coma Scale — Detailed Breakdown

ComponentResponseScore
Eye (E)Spontaneous4
To voice3
To pain2
None1
Verbal (V)Oriented5
Confused4
Inappropriate words3
Sounds2
None1
Motor (M)Obeys commands6
Localises5
Withdraws (normal flexion)4
Abnormal flexion (decorticate)3
Extension (decerebrate)2
None1
This patient: E4V3M6 = GCS 13
GCS RangeSeverity Classification
13–15Mild TBI
9–12Moderate TBI
≤ 8Severe TBI — intubation mandatory
This patient (GCS 13) is mild by score, but:
  • V3 (inappropriate words) — confused, not oriented
  • Being rushed for decompressive craniotomy → rapid neurological deterioration expected
  • Any GCS decline below 9 while in your care → intubation is mandatory without further delay
  • "Patients can talk and deteriorate, or talk and die" after TBI with LOC — Miller's explicit warning
"Patients with good scores can talk and deteriorate or talk and die after a TBI associated with loss of consciousness. Delayed deterioration has been observed as much as 4 days after the initial injury."Miller's Anesthesia, 10e (Chapter 53)

1.2 World Federation of Neurological Surgeons (WFNS) Scale

WFNS GradeGCS ScoreMotor Deficit
I15Absent
II13–14Absent
III13–14Present
IV7–12Absent or present
V3–6Absent or present
This patient: GCS 13 with RTA injury — if motor deficit present → Grade III; if absent → Grade II
Higher WFNS grade = worse clinical outcome

1.3 Hunt–Hess Classification (SAH — Table 53.3, Miller's)

Applicable here because this patient has traumatic SAH (tSAH):
GradeCriteria
IAsymptomatic, or minimal headache and slight nuchal rigidity
IIModerate–severe headache, nuchal rigidity, no deficit other than CN palsy
IIIDrowsiness, confusion, or mild focal deficit
IVStupor, moderate–severe hemiparesis, possible early decerebrate rigidity
VDeep coma, decerebrate rigidity, moribund appearance
This patient (V3 = confused speech, drowsy): Likely Hunt-Hess Grade III
"Serious systemic disease such as hypertension, diabetes, severe arteriosclerosis results in placement of the patient in the next less-favourable category." — Miller's footnote to table

1.4 Fisher / Modified Fisher Scale — CT Classification of SAH

Used to predict vasospasm risk after SAH:
Fisher Scale (Table 80.8):
GradeCT Findings
1No blood detected
2Diffuse SAH, no clots, blood layer < 1 mm
3Localised clots and/or vertical blood ≥ 1 mm
4Diffuse/no SAH, but intracerebral or intraventricular clots
Modified Fisher Scale (Table 80.9):
GradeCT Findings
0No blood
1Thin SAH, no IVH
2Thin SAH, with IVH
3Thick SAH, no IVH
4Thick SAH, with IVHhighest vasospasm risk
"The highest incidence of vasospasm is observed in patients with modified Fisher grade 4."
In RTA with tSAH + SDH → typically thick blood, likely Modified Fisher 3–4

1.5 Traumatic SAH Epidemiology

"Traumatic SAH (tSAH) occurs in up to 60% of admissions for TBI and influences outcome. Approximately 20% of patients with tSAH may also develop vasospasm, which causes secondary ischaemic insult."Miller's Anesthesia, 10e (Chapter 80)

1.6 TBI Severity Classification

ClassificationGCSMortality
Mild13–15Low
Moderate9–12Intermediate
Severe≤ 8High — 3× that of other trauma
"Severe TBI is classified as GCS ≤ 8 at admission and carries significant mortality. Patients with severe TBI have mortality three times that of patients with other types of traumatic injury."

PART 2 — PATHOPHYSIOLOGY: PRIMARY AND SECONDARY BRAIN INJURY

2.1 Primary Injury

  • Direct mechanical injury at time of impact: axonal shearing, cortical laceration, haematoma
  • Cannot be influenced by therapy — prevention (helmets, airbags) is the only protection

2.2 Secondary Brain Injury — What the Anaesthetist Targets

MechanismContributor
Elevated ICP (oedema, haematoma, CSF obstruction)Reduced CPP
Loss of cerebrovascular autoregulationPressure-passive CBF
Tissue hypoxia and ischaemiaAnaerobic metabolism
Excitotoxicity (glutamate release)Neuronal death
Inflammation and cytokine releaseOedema propagation
Free radical generationMembrane damage
Apoptotic cell deathDelayed neuronal loss
ATP depletionEnergy failure
Intracellular Ca²⁺ accumulationCell death
The single biggest modifiable cause of secondary injury: Hypotension + Hypoxia
"A single episode of hypoxaemia (PaO₂ < 60 mmHg) occurring in a patient with severe TBI can double the incidence of mortality."
"A single episode of hypotension (SBP < 90 mmHg) is associated with an increase in morbidity and doubled mortality after severe TBI."

2.3 CBF Pattern After TBI

Time Post-injuryCBF Pattern
0–24 hoursLow CBF (oligaemic phase) — most vulnerable
24–72 hoursGradual normalisation
72+ hoursMay develop hyperaemia (especially in mass lesion patients)
Key implication: Hypotension during initial 24–72 hours causes ischaemia even at blood pressures normally considered acceptable.

PART 3 — PREOPERATIVE ASSESSMENT AND PREPARATION

3.1 Immediate Assessment — ABCDE + Neurological Exam

ComponentAssessmentRelevance
A — AirwayPatent vs threatened? Tongue fall, blood, secretionsGCS 13 now but may deteriorate rapidly
B — BreathingSpO₂, RR, auscultationHypoxia doubles TBI mortality
C — CirculationBP, HR, peripheral perfusionHypotension doubles TBI mortality
D — DisabilityGCS (E4V3M6 = 13), pupils (size, reactivity, equality), lateralising signsPupil changes = transtentorial herniation
E — ExposureFull body exam for associated injuriesPolytrauma common in RTA
Cervical spineUntil cleared by CT — treat as unstableRelevant for airway management

3.2 Pupil Assessment — Herniation Warning Signs

Pupil FindingSignificance
Unilateral fixed dilated pupilUncal herniation compressing CN III ipsilaterally → emergency
Bilateral fixed dilatedAdvanced bilateral herniation or severe hypoxia
Bilateral constricted (pinpoint)Pontine damage or opioid effect
Anisocoria (>1 mm)May indicate early herniation

3.3 Cushing's Triad — Impending Brainstem Herniation

SignMechanism
Hypertension (systolic ↑)Brainstem vasomotor centres stimulated
BradycardiaBaroreceptor reflex to hypertension
Irregular/slow respirationsBrainstem compression
If Cushing's triad is present → herniation is imminent → proceed to OR without delay; mannitol/HTS in transit

3.4 Preoperative Investigations

InvestigationWhat to Look For
CT Head (already done — SDH + SAH)Midline shift, cisternal effacement, Fisher grade, haematoma volume
CT Cervical spineBony injury cleared by modern multislice CT
ABGPaO₂, PaCO₂, base excess, lactate
CBCHaemoglobin, platelets
Coagulation (PT, APTT, INR, fibrinogen)Trauma coagulopathy; Acute Traumatic Coagulopathy
Electrolytes, BUN, creatinineBaseline; hyponatraemia watch
Blood glucoseNormoglycaemia target
Group and crossmatchAnticipate blood loss
ECGSAH-associated cardiac changes
TroponinSAH myocardial stunning
Echocardiogram (if time permits)Takotsubo/neurogenic stunning

3.5 SAH-Associated Cardiac Changes — Critical for Anaesthetist

FindingSignificance
Canyon T waves (deep, wide T waves)Classic ECG sign of SAH
QTc prolongation > 550 msecRisk of torsades de pointes
ST-segment depressionCommon — does not usually represent ischaemia
Q-T prolongationAssociated with more severe SAH
Troponin elevationTypically below AMI threshold; correlates with neurological injury severity
Echocardiographic dysfunctionObserved in some patients with SAH — Takotsubo pattern
"Troponin elevation occurs commonly, though typically reaching levels less than the diagnostic threshold for myocardial infarction. Peak troponin levels correlate with the severity of both neurologic injury and echocardiographic dysfunction."
"An increased QTc interval (> 550 msec) occurs frequently after SAH and has been associated with an increased incidence of malignant ventricular rhythms including torsades de pointes."
Takotsubo cardiomyopathy may also develop after severe TBI due to catecholamine surge:
  • Subendocardial ischaemia → biventricular failure
  • Even in young, previously healthy patients
  • β-adrenergic blockade may be protective

PART 4 — AIRWAY MANAGEMENT

4.1 Challenges Specific to This Patient (Box listing — Miller's Chapter 53)

ChallengeReason
Full stomachRTA — unknown last meal; delayed gastric emptying
Uncertain cervical spine stabilityRTA mechanism until CT cleared
Uncertain airwayFacial trauma, blood in oropharynx, laryngeal injury possible
Blood in airwayCompound fractures, basal skull fracture
Skull base fractureContraindication to nasogastric tube placement
Uncertain volume statusHaemorrhage possible
Uncooperative/combativeV3 — confused
HypoxaemiaFrom any associated chest injury or aspiration
Increased ICPLaryngoscopy will cause pressor response → ↑ ICP

4.2 Technique: Modified RSI with In-Line Stabilisation

  • Rapid Sequence Induction (RSI) — standard approach for all trauma patients with full stomach + TBI
  • In-line axial stabilisation (not traction) — limits atlanto-occipital extension
  • Back half of cervical collar may be left in place — acts as strut, limits extension
  • Cricoid pressure applied
"Although in-line stabilisation properly performed makes laryngoscopy more difficult, it serves to decrease the amount of atlanto-occipital extension necessary to achieve visualisation of the glottis."
"In a resuscitation situation, before initiating a hypnotic-relaxant sequence, confirm the availability of cricothyrotomy equipment."

4.3 RSI Drug Choices for This Patient

DrugRoleNotes
Preoxygenation3–5 min 100% O₂Mandatory — hypoxia during apnoea must be prevented
Fentanyl 2–3 mcg/kg IVAttenuate laryngoscopy pressor response3 minutes before induction
Lignocaine 1–1.5 mg/kg IVAttenuate ICP rise during laryngoscopy3–4 minutes before
Propofol 1.5–2 mg/kgInduction: ↓ CMR, ↓ CBF, ↓ ICPWatch hypotension — have vasopressors ready
Thiopentone 3–5 mg/kgAlternative to propofol; maximum ICP reductionMay cause severe hypotension
Rocuronium 1.2 mg/kgNMB for RSIPREFERRED over succinylcholine; sugammadex available
Succinylcholine 1.5 mg/kgMay cause small ICP increase"Should not be viewed as contraindicated in TBI" — Miller's; use if rocuronium not available
Vasopressor (phenylephrine/norepinephrine)Treat induction-related hypotensionMust be immediately available
"The necessity to use succinylcholine in these circumstances has diminished with the availability of both rocuronium and the reversal agent sugammadex." — Miller's
"As is the case in many other situations, the laryngeal mask may be a very useful device for temporising in the face of a failed intubation and may also provide access for intubation as an alternative to cricothyrotomy."

4.4 Cervical Spine Management

  • Modern multislice CT alone is sufficient to rule out unstable bony cervical spine injuries
  • MRI may identify ligamentous injury CT misses — but in emergency, clinical urgency prevails
  • Cricothyrotomy/tracheostomy rate at major trauma centre (Cowley Shock Trauma Centre): 0.3%
  • Video laryngoscope reduces need for head extension — preferred in RTA patients

PART 5 — INTRAOPERATIVE MONITORING

MonitorPriority
Invasive arterial line (radial)Essential — beat-to-beat BP; ABG sampling
SpO₂ (pulse oximetry)Standard
Capnography (EtCO₂)Ventilation guidance; correlate with PaCO₂ (typical gradient 3–5 mmHg)
ECGSAH cardiac changes; arrhythmia detection
TemperatureCore temp (oesophageal/rectal)
Foley catheter + urine outputOsmotherapy monitoring, fluid balance
Central venous accessFor vasopressors, CVP monitoring
ICP monitorParenchymal or EVD (if placed pre-op or intraoperatively)
BIS / processed EEGDepth of anaesthesia
TOF (Train-of-Four)NMB monitoring — avoid coughing/straining
Precordial DopplerIf significant SAH sinus involvement → VAE risk
"The anesthesiologist should appreciate that the priority is to open the cranium as rapidly as possible. After achieving IV access, the risks and benefits of delaying craniotomy for line placement should be considered carefully. An arterial line, often placed after induction in urgent situations, is appropriate for essentially all acute trauma craniotomies."
"Sudden hypotension after dural opening with high ICP can occur as brainstem compression is relieved. Appropriate intravascular volume resuscitation should mitigate this occurrence."

PART 6 — HAEMODYNAMIC TARGETS AND BLOOD PRESSURE MANAGEMENT

6.1 Non-Negotiable Targets

ParameterTargetRationale
ICP< 20–22 mmHgTreatment threshold
CPP60–70 mmHgMain driver of brain oxygenation
MAPMaintain within 10% of awake valuesEspecially important in SAH patient
SBP (15–49 yrs or >70 yrs)110 mmHgAbsolute minimum
SBP (50–69 yrs)100 mmHgAbsolute minimum
SBP (do not allow)< 90 mmHgDoubles mortality
CPP (aggressive — avoid)> 90 mmHgIncreases respiratory failure risk

6.2 SAH-Specific Blood Pressure

Before aneurysm is secured (though this is traumatic SAH, not aneurysmal):
"Absolute avoidance of acute hypertension with its attendant risk of rebleeding." "Maintenance of a high-normal MAP to prevent critical reduction of CBF in recently insulted and now marginally perfused areas of brain."
For traumatic SAH proceeding to craniotomy:
  • Target MAP high-normal
  • Hypotension is the enemy (vasoconstriction from tSAH may already compromise CBF)
  • Pressor augmentation target: increase MAP by 20–30 mmHg above baseline SBP

6.3 Three BP Management Concepts (Miller's Chapter 53)

ConceptCPP TargetDescription
Standard (BTF/AANS)60–70 mmHgCurrent recommended standard
Lund Concept50–60 mmHg when ICP uncontrolledControversial; normovolaemia + metoprolol + clonidine
Rosner ConceptInduced hypertensionBased on preserved autoregulation; now few advocates
For this patient: standard BTF approach (CPP 60–70 mmHg)

PART 7 — ANAESTHETIC TECHNIQUE FOR DECOMPRESSIVE CRANIOTOMY

7.1 Drug Selection Principles

"Craniotomies are most commonly performed for the evacuation of subdural, epidural, or intracerebral haematomas. In general, anaesthetics that are known to be cerebral vasoconstrictors are preferable to those that have the potential to dilate the cerebral circulation."
Drug ClassEffect on ICP/CBFUse
Propofol↓ CMR, ↓ CBF, ↓ ICP✅ Preferred induction + TIVA maintenance
ThiopentoneStrong ↓ CMR, ↓ ICP✅ Alternative; barbiturate rescue
Fentanyl/Sufentanil/RemifentanilNo ICP effect when MAP maintained✅ Freely use
Rocuronium/VecuroniumNo ICP effect✅ Preferred NMB
Sevoflurane (< 1 MAC)Minimal ICP at low concentration✅ Acceptable at < 1 MAC
N₂O↑ CMR, ↑ CBF, expands pneumocephalusAVOID — absolute contraindication in TBI/SAH, compound fracture, air in head
KetamineAcceptable in intubated/ventilated patients✅ In ventilated patients; hemodynamically favourable
Volatile agents > 1 MACCerebral vasodilation → ↑ ICPAvoid when ICP uncontrolled
Etomidate↓ seizure threshold; ↓ brain PO₂ (demonstrated in clinical study with aneurysm clipping)Avoid
"When the ICP is out of control (or unknown), or the surgical field is tight, omitting the inhaled anaesthetics in favour of intravenous agents is appropriate."
"For patients who are likely to remain intubated post-operatively, an anaesthetic based primarily on a narcotic, such as fentanyl, and a muscle relaxant usually serves well."

7.2 Recommended Anaesthetic Plan

Induction (RSI):
  • Pre-oxygenation × 5 min
  • Fentanyl 2 mcg/kg + Lignocaine 1.5 mg/kg IV (3 min before)
  • Propofol 1.5–2 mg/kg (titrated, watch BP) + Rocuronium 1.2 mg/kg
  • Cricoid pressure + in-line stabilisation
  • Video laryngoscope preferred
Maintenance:
  • TIVA preferred: Propofol infusion (4–8 mg/kg/hr) + Remifentanil infusion (0.05–0.2 mcg/kg/min)
  • Alternative: Sevoflurane < 1 MAC + Fentanyl infusion (NO N₂O)
  • BIS-guided depth (target BIS 40–60)
  • Rocuronium infusion or repeat bolus (TOF-guided)

PART 8 — VENTILATION STRATEGY

ParameterTargetNotes
PaO₂80–120 mmHgNormoxia
PaCO₂35–38 mmHgNormocapnia standard
SpO₂≥ 95%Minimum
If ICP > 20–25 mmHgHyperventilate to PaCO₂ 30–35 mmHgShort-term only — bridge to definitive surgery
Minimum PaCO₂23–25 mmHgNever lower — ischaemia risk without further ICP benefit
Prophylactic hyperventilation❌ Not recommendedEspecially in first 24 hours of TBI (critically low baseline CBF)
PEEPUp to 15 cmH₂O if neededDoes not increase ICP when adequately volume resuscitated
Tidal volume6–8 mL/kg IBWLung protective strategy
"Hyperventilation to PaCO₂ of 25 mm Hg, long a mainstay of managing TBI, is no longer recommended as prophylactic treatment. A range of PaCO₂ between 30 and 35 mmHg should be induced only for episodes of increased ICP that cannot be controlled with other means."

PART 9 — ICP MANAGEMENT (INTRAOPERATIVE)

Box 53.3 — "Tight Brain" Checklist (Applied Intraoperatively)

1. Relevant pressures controlled?
  • Jugular venous pressure — head rotation? Extreme neck flexion? Head-up position maintained?
  • Airway pressure — obstruction, bronchospasm, coughing/straining, pneumothorax, excessive PEEP?
  • PaCO₂ and PaO₂ — normalised?
  • Arterial pressure — MAP adequate?
2. Metabolic rate controlled?
  • Pain/arousal adequate?
  • Seizures occurring?
  • Febrile?
3. Potential cerebral vasodilators in use?
  • N₂O? Volatile agents at high concentration? Nitroprusside? Calcium channel blockers?
4. Unrecognised mass lesions?
  • Expanding SDH? Intracerebral haematoma? Air ± N₂O?

Box 53.4 — Rapid ICP Reduction Measures (Escalating Order)

  1. Further reduce PaCO₂ to 23–25 mmHg (not below)
  2. CSF drainage — EVD open if in situ
  3. Diuresis — furosemide
  4. CMR suppression — propofol bolus, barbiturate
  5. MAP reduction (only if dysautoregulation proven)
  6. Hyperosmolar therapy:
    • Mannitol 0.25–1 g/kg IV over 10–15 min
    • HTS bolus (3%, 7.5%, or 23.4% via central line)
  7. Surgical control — remove bone flap (the procedure itself is the ultimate ICP rescue)

Brain Relaxation for Decompressive Craniotomy

"Surgeons who believe in CBF-enhancing effect of mannitol may request a second 1 g/kg approximately 15 minutes before anticipated temporary occlusion."
ManoeuvreNotes
Mannitol 1 g/kg (just before dural opening)Standard for brain relaxation
Mannitol up to 2 g/kgSome surgeons use aggressively
Lumbar CSF drainOpen after surgeon opens dura; close before retractor withdrawal
Head-up 20–30°Venous drainage optimisation
Normocapnia (or mild hypocapnia if ICP uncontrolled)PaCO₂ 35–38 or 30–35
Avoid coughing/strainingNMB maintained
Warning: Sudden reduction of ICP after CSF drainage may cause rebleeding from SAH aneurysm equivalent mechanism (transmural pressure gradient change). Avoid excessive CSF drainage.

PART 10 — OSMOTHERAPY: MANNITOL vs HYPERTONIC SALINE

FeatureMannitol 20%Hypertonic Saline (HTS)
Dose0.25–1 g/kg (up to 1.5 g/kg for surgery)3%: variable; 7.5–23.4%: bolus
RoutePeripheral IVCentral line if > 7.5%
SpeedOver 10–15 min (not bolus)Bolus
Effect onset15–30 min15–30 min
DurationDose-dependentSimilar to mannitol
Serum osmolarity limit~320 mOsm/L
Renal effectCauses diuresis → monitor volumeRetains volume
ICU preferenceTraditional intraoperative first-lineIncreasing use, especially refractory ICP
SuperioritySimilar initial ICP effectMay have advantage in TBI combined ICP/CPP burden
Furosemide combinationUsed to maintain osmotic gradient
"Mannitol should be administered by infusion (e.g., over 10–15 minutes). Sudden exposure to extreme hyperosmolarity can have a vasodilatory effect, causing brain engorgement and increased ICP."

PART 11 — FLUID MANAGEMENT

FluidRecommendation
0.9% NaCl (normal saline)✅ Acceptable — isotonic
Plasmalyte / Hartmann's✅ Balanced crystalloid — preferred
5% Dextrose / hypotonic solutionsAbsolutely forbidden — worsens cerebral oedema
Albumin in TBIAvoid — SAFE trial: increased mortality (GCS 3–8 subgroup)
HES (hydroxyethyl starch)Avoid — renal injury, coagulopathy
Blood transfusionWhen Hb < 7–10 g/dL
Haemoglobin target in TBI≥ 10 g/dL (Hb < 10 may be detrimental to TBI recovery per animal + human studies)

Haemoglobin and TBI

"A haemoglobin lower than 7 g/dL results in impaired brain function and a haemoglobin lower than 10 g/dL may be detrimental to recovery from TBI."

PART 12 — TRAUMATIC SAH-SPECIFIC CONSIDERATIONS

Vasospasm After Traumatic SAH

  • Incidence: ~20% of tSAH patients develop vasospasm
  • Timing: peaks 4–14 days after SAH
  • Risk higher with: large blood clot (Fisher 3–4), IVH, thick SAH
  • Monitoring: TCD (transcranial Doppler), CT perfusion, cerebral angiography, cEEG (in high-grade patients)

Treatment of Vasospasm / DCI

TreatmentStatus
Nimodipine oral (60 mg q4h for 21 days)Level I evidence — only RCT-proven therapy in SAH; reduces ischaemic deficit (but NOT angiographic vasospasm)
Euvolaemia✅ Current standard
Vasopressors (MAP augmentation: +20–30 mmHg above baseline SBP)✅ For DCI
Cardiac output monitoring + optimisation✅ (dobutamine augments CBF in ischaemic territories without MAP rise)
Triple-H therapy (Hypertension–Hypervolaemia–Haemodilution)NO LONGER RECOMMENDED — RCT/meta-analysis showed no benefit and potential harm
Balloon angioplasty / intraarterial vasodilators (verapamil, nicardipine, nimodipine, papaverine, milrinone)For medically refractory vasospasm
Transfusion thresholdMaintain haematocrit > 25% (haemodilution target traditionally low 30s for optimal rheology, but transfusion for DCI is controversial)
Magnesium❌ No improvement in outcome (large RCT negative)
Statins❌ Meta-analysis showed only nonsignificant trends
Endothelin antagonist (clazosentan)❌ Improved mortality without improving outcome
Antifibrinolytics (TXA/aminocaproic acid)For delayed surgery, < 72 hours, selected cases only — no outcome improvement

SIADH vs Cerebral Salt Wasting (CSW) After SAH

Both cause hyponatraemia — but treatment is opposite:
FeatureSIADHCSWS
MechanismExcess ADH → water retentionNatriuretic peptide → Na⁺ loss + volume depletion
Volume statusNormo- to hypervolaemiaHypovolaemia
Urine Na⁺High (> 20–50 mmol/L)Very high (> 50 mmol/L)
TreatmentFluid restrictionIV isotonic or hypertonic saline
Risk if mistreatedCSWS treated with fluid restriction → dangerous hypovolaemia → ↓ CPP → DCI
"Fluid restriction and further volume contraction may be especially deleterious in the post-SAH patient and should be avoided."

PART 13 — DECOMPRESSIVE CRANIOTOMY — SURGICAL AND ANAESTHETIC SPECIFICS

Indications for Decompressive Craniectomy

Indication
Refractory ICP despite medical therapy (all tiers)
ICP not maintainable despite barbiturate coma
CPP cannot be maintained despite vigorous therapies
Mass lesion causing herniation (SDH in this patient)
"Decompressive craniectomy is indicated for selected anatomic patterns of TBI, such as when CPP cannot be maintained despite the vigorous application of the previously described therapies, including barbiturate coma."

Miller's Warning on Decompressive Craniectomy

"Decompressive craniectomy has been a strategy to lower ICP, but unfortunately this intervention increases the number of patients surviving in a vegetative state or with severe brain damage."
"The updated recommendations of the Brain Trauma Foundation (BTF) now suggest decompressive craniectomy only in patients with late refractory increased ICP, but not in patients with early refractory increased ICP."
However, for SDH with herniation (as in this patient): Craniotomy and haematoma evacuation is standard acute treatment — not purely decompressive craniectomy for medical refractory ICP.

Haemodynamic Events at Dural Opening

EventCauseManagement
Sudden hypotension at dural openingSudden ICP release → vasodilatation; decompression of brainstem cardiovascular centresPre-load with IV fluids; vasopressors immediately available
Brain herniation through openingExtreme ICP or inadequate decompressionSurgical issue; position head correctly; ensure adequate opening
Hyperaemia / engorgement after haematoma evacuationReperfusion of previously compressed tissueControl BP; avoid hyperthermia

PART 14 — BLOOD PRESSURE MANAGEMENT IN COMBINED SDH + TRAUMATIC SAH

This patient has BOTH conditions — a unique challenge:
ConditionBP Requirement
SDH with raised ICPMaintain MAP to protect CPP; avoid hypotension
Traumatic SAH (pre-haematoma secured)Avoid acute hypertension → rebleeding; avoid hypotension → vasospasm-related ischaemia
Balance pointMaintain MAP near patient's awake baseline (within 10%); use norepinephrine/phenylephrine
"For patients proceeding to surgery, hypotension should be avoided and CPP should usually be maintained intraoperatively at values near the waking normal range."
Vasopressor Choice:
  • Norepinephrine — preferred; maintains MAP without direct cerebral vasodilation
  • Phenylephrine — pure α₁-agonist; acceptable; may cause reflex bradycardia
  • Dopamine — second-line; may cause arrhythmias, especially with SAH-related cardiac changes
  • Phenylephrine and dopamine — most commonly used pressors in SAH per Miller's

PART 15 — EMERGENCE AND POSTOPERATIVE PLAN

Extubation Decision

CriterionDecision
Pre-op GCS was 13 (borderline) + SDH evacuated + haemostasis achievedConsider trial of extubation only if neurological improvement
SDH evacuated but SAH still presentKeep intubated for ICU monitoring
Intraoperative brain swelling or difficult haemostasisRemain intubated
GCS trend decliningRemain intubated
Hunt-Hess Grade III (confusion)Remain intubated — airway not safe, vasospasm monitoring needed
Standard practice for decompressive craniotomyPlan for post-op intubation in ICU
"For patients who are likely to remain intubated post-operatively, an anaesthetic based primarily on a narcotic (fentanyl) and a muscle relaxant usually serves well."

Smooth Emergence (If Extubating)

  • Lignocaine 1 mg/kg IV 5 min before extubation
  • Remifentanil titration to extubation
  • Dexmedetomidine 0.4–0.7 mcg/kg/hr — reduces coughing
  • Extubate only when fully awake and cooperative
  • Avoid Valsalva, bucking, sudden hypertension

ICU Post-op Management

TargetValue
ICP< 22 mmHg
CPP60–70 mmHg
PaCO₂35–38 mmHg
PaO₂80–120 mmHg
TemperatureNormothermia (every 1°C fever ↑ CMR ~7%)
Blood glucose6–10 mmol/L (140–180 mg/dL) — avoid both hyperglycaemia and hypoglycaemia
Haemoglobin≥ 10 g/dL
Serum sodium135–145 mmol/L; treat CSWS vs SIADH correctly
Nimodipine60 mg orally q4h × 21 days (for SAH)
Seizure prophylaxisShort-term (≤ 7 days); avoid phenytoin
DVT prophylaxisMechanical only (TED stockings, pneumatic compression); no chemical anticoagulation with fresh craniotomy
Repeat CT head24 hours or any neurological deterioration
Neurological assessmentHourly GCS + pupil check

PART 16 — IMPORTANT SUMMARY: "MUST KNOWS" FOR MD EXAM

Critical Numbers at a Glance

ParameterNumber
ICP treatment threshold> 22 mmHg
CPP target range60–70 mmHg
SBP minimum (15–49, >70 yrs)110 mmHg
SBP minimum (50–69 yrs)100 mmHg
Single episode SBP < 90 effectDoubles mortality
Single episode PaO₂ < 60 mmHgDoubles mortality
Traumatic SAH in TBI admissionsUp to 60%
Vasospasm in tSAH~20%
PaCO₂ standard target35–38 mmHg
PaCO₂ rescue hyperventilation30–35 mmHg
PaCO₂ minimum (never below)23–25 mmHg
CBF normalisation after hyperventilation8–12 hours
Nimodipine duration21 days
Triple-H therapy❌ NO LONGER RECOMMENDED
Mannitol dose0.25–1 g/kg (up to 2 g/kg by surgeon)
Serum osmolarity limit with mannitol~ 320 mOsm/L
Haemoglobin target in TBI10 g/dL
QTc threshold for torsades risk (SAH)> 550 msec
Temporary vessel occlusion ischaemic threshold< 14 min safe; > 31 min = 100% injury
Decompressive craniectomy BTF indicationLate refractory ICP (not early)
Albumin in TBIAvoid (SAFE trial)
Steroids in TBIAvoid (increased mortality — CRASH trial)
N₂O in TBI/SAHAbsolute contraindication
Etomidate❌ Avoid — ↓ brain PO₂, ↑ seizure risk

REFERENCES — Miller's Anesthesia, 10e

  • Chapter 53: Neuroanesthesia — ICP control, SAH anaesthetic technique, Hunt-Hess, WFNS, Fisher scales, airway challenges in TBI, osmotherapy, brain protection, Boxes 53.1/53.3/53.4, Tables 53.1/53.3
  • Chapter 62: Trauma Anaesthesia — Decompressive craniectomy indication, TBI management algorithm, RSI, cervical spine, haemoglobin targets, ARDS + TBI double-hit
  • Chapter 80: Neurocritical Care — Traumatic SAH incidence/vasospasm, TBI pathophysiology/treatment, CPP/ICP stepwise algorithm, CSWS vs SIADH, Box 80.3, Tables 80.3/80.4/80.8/80.9

One-Line Clinical Rule for this Patient: GCS 13 with SDH + tSAH going for decompressive craniotomy = treat as deteriorating severe TBI; RSI with rocuronium; TIVA propofol; NO N₂O; NO hypotension; NO steroids; NO albumin; normocapnia unless herniating; mannitol before dural opening; plan for ICU intubated post-op; start nimodipine for 21 days.Your credits are exhausted. Your daily credits reset tomorrow, or you can purchase a top-up for more.

Retry please

Your credits are exhausted. Your daily credits reset tomorrow, or you can purchase a top-up for more.

Using millers anaesthesiology discuss in orderly fashion about volatile anaesthetic agents, their history, physics, classification, implications, reaction with other drugs, and volatile anaesthetic agents of choices in various surgeries, paediatric, adults, obstetrics, geriatrics, etc etc

Checking Date & Time
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Good — block 6 contains inhaled anaesthetic content. Let me read more of this block and the core chapters systematically:
Reading File
Reading File
This block is primarily references. Let me search for the core volatile anaesthetics chapter content more strategically:
Reading File
I have now gathered substantial content from Miller's across multiple blocks. Given the budget constraints, I have sufficient material from the textbook to write a comprehensive, well-structured answer. Let me now synthesize the complete discussion:
This is a shared conversation. Sign in to Orris to start your own chat.